Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using ¹⁸F-FDG PET/CT

J Nucl Med. 2020 Sep;61(9):1404-1405. doi: 10.2967/jnumed.120.242768. Epub 2020 Feb 21.

Authors

Romain-David Seban, Lawrence H Schwartz, Gerald Bonardel, Laurent Dercle¹

Affiliation

¹ Department of Radiology at Columbia University Medical Center/NewYork-Presbyterian Hospital 168th St. New York, NY 10032 E-mail: [email protected].

PMID: 32086243
DOI: 10.2967/jnumed.120.242768

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung*
Fluorodeoxyglucose F18
Humans
Lung Neoplasms*
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Radiopharmaceuticals

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18